ORIGINAL ARTICLE
Human papilloma virus infection in basal cell carcinoma of the skin: a systematic review and meta-analysis study
Submission date: 2017-05-15
Final revision date: 2017-10-24
Acceptance date: 2017-10-28
Publication date: 2018-03-06
Pol J Pathol 2017;68(4):330-342
KEYWORDS
TOPICS
ABSTRACT
Human papillomaviruses (HPVs) are a large and ubiquitous group of viruses that some of them have been suggested as a co-factor in the development of non-melanoma skin cancers. The aim of this meta-analysis study was to evaluate HPVs’ prevalence in basal cell carcinoma (BCC) of the skin and the risk of them in the BCC patients compared with the healthy controls. Five databases were searched from January 1980 to February 2017. A random-effects meta-analysis was done with the event rate (ER) for the prevalence of HPVs and odds ratio (OR) for estimation of the incidence of HPVs. Out of 1087 studies, 45 studies were included in the review. The pooled analysis demonstrated that the incidence of γ-HPV was effective in the BCC patients compared with the healthy controls [OR = 1.97; 95% CI: 1.52-2.55; p < 0.00001], but not for α-HPV, β-HPV and epidermodysplasia verruciformis (EV)-HPV (p > 0.05). The pooled ER of incidence of β1-HPV in the BCC patients was z3.3% and for β2-HPV in BCC patients was 44.2%. In conclusion, this meta-analysis showed that probably the risk of γ-HPV was more on BCC patients and also the rate of γ-HPV was higher than α-, β- and EV-HPVs in the BCC patients.
REFERENCES (52)
1.
Correa RM, Vladimirsky S, Heideman DA, et al. Cutaneous human papillomavirus genotypes in different kinds of skin lesions in Argentina. J Med Virol 2017; 89: 352-357.
2.
Drvar DL, Lipozencić J, Sabol I, et al. Human papillomavirus status in extragenital nonmelanoma skin cancers. Clin Dermatol 2014; 32: 248-252.
3.
Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30: F12-23.
4.
Bernard HU, Burk RD, Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-79.
5.
Zakrzewska K, Regalbuto E, Pierucci F, et al. Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients. Virol J 2012; 9: 309.
6.
Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000; 97: 12513-12518.
7.
Kreuter A, Hochdorfer B, Brockmeyer NH, et al. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. Arch Dermatol 2008; 144: 366-372.
8.
Bernat-García J, Morales Suárez-Varela M, Vilata-Corell JJ, et al. Detection of human papillomavirus in nonmelanoma skin cancer lesions and healthy perilesional skin in kidney transplant recipients and immunocompetent patients. Actas Dermosifiliogr 2014; 105: 286-294.
9.
Mokhtari M, Mesbah A, Rajabi P, et al. Determination of the relationship between Basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol 2009; 54: 225-228.
10.
Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, et al. Epidemiology and etiology of basal cell carcinoma. Br J Dermatol 2007; 157: 47-51.
11.
Escutia B, Ledesma E, Serra-Guillen C, et al. Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects. J Eur Acad Dermatol Venereol 2011; 25: 832-838.
12.
Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73.
13.
Trenfield K, Salmond CA, Pope JH, et al. Southern blot analysis of skin biopsies for human papillomavirus DNA: renal allograft recipients in south-eastern Queensland. Australas J Dermatol 1993; 34: 71-78.
14.
Rotaru M, Iancu G, Mihalache M, et al. -HPV positivity analysis in a group of patients with melanoma and non-melanoma skin cancers. Rom J Lab Med 2014; 22: 471-478.
15.
Elwood H, Kim J, Yemelyanova A, et al. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol 2014; 38: 542-547.
16.
Iannacone MR, Gheit T, Waterboer T, et al. Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol 2013; 133: 1512-1520.
17.
Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389-395.
18.
Gibson GE, Ahmed I. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases. J Am Acad Dermatol 2001; 45: 68-71.
19.
Pierceall WE, Goldberg LH, Ananthaswamy HN. Presence of human papilloma virus type 16 DNA sequences in human nonmelanoma skin cancers. J Invest Dermatol 1991; 97: 880-884.
20.
Karagas MR, Spencer SK, Weinstock MA, et al. Rarity of Human Papillomavirus in Nonmelanoma Skin Cancer among Immunocompetent Patients. J Cutan Med Surg 1997; 2: 16-19.
21.
Patel AS, Karagas MR, Perry AE, et al. Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol 2008; 128: 2888-2893.
22.
Karagas MR, Waterboer T, Li Z, et al. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010; 341: c2986.
23.
Rollison DE, Pawlita M, Giuliano AR, et al. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer 2008; 123: 2337-2342.
24.
Iannacone MR, Wang W, Stockwell HG, et al. Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis 2012; 206: 399-406.
25.
Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994; 131: 226-230.
26.
de Jong-Tieben LM, Berkhout RJ, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367-371.
27.
Berkhout RJ, Bouwes Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-2096.
28.
Feltkamp MC, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695-2700.
29.
Berberta ALCV, Manteseb SADO, Filhoc LRG, et al. Detection of Human Papillomavirus in Basal Cell Carcinoma by Polymerase Chain Reaction. Med Cutan Iber Lat Am 2004; 32: 205-209.
30.
Yang JF, Zhao CZ, Lu KX. Development and application of a rapid detection system for human papillomavirus and Herpes simplex virus-2 by loop-mediated isothermal amplification assay. Microb Pathog 2016; 97: 178-182.
31.
Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297.
32.
Nahidi Y, Meibodi NT, Meshkat Z, et al. No Evidence of Human Papilloma Virus Infection in Basal Cell Carcinoma. Indian J Dermatol 2015; 60: 356-359.
33.
Ramezani M, Abdali E, Khazaei S, et al. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran. Asian Pac J Cancer Prev 2016; 17: 1093-1096.
34.
Shahmahmoudi S, Mahmoodi M, Azad TM, et al. Prevalence of mucosal types of human papillomavirus in skin lesions in north part of Iran. Cancer Lett 2007; 247: 72-76.
35.
Luron L, Avril MF, Sarasin A, et al. Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients. Cancer Lett 2007; 250: 213-219.
36.
Iftner A, Klug SJ, Garbe C, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003; 63: 7515-7519.
37.
Zaravinos A, Kanellou P, Spandidos DA. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers. Br J Dermatol 2010; 162: 325-331.
38.
Biliris KA, Koumantakis E, Dokianakis DN, et al. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett 2000; 161: 83-88.
39.
Forslund O, Lindelöf B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in “Stripped” biopsies from the same tumors. J Invest Dermatol 2004; 123: 388-394.
40.
Reuschenbach M, Tran T, Faulstich F, et al. High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients. Br J Cancer 2011; 104: 1334-1341.
41.
Stockfleth E, Nindl I, Sterry W, et al. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30: 604-609.
42.
Posteraro P, Didona B, Papi M, et al. Analisi del DNA di papillomavirus umani (HPV) mediante reazione polimerasica a catena (PCR) in lesioni cutanee tumorali. Dermatologia Clinica 1996; 16 (1).
43.
Paolini F, Carbone A, Benevolo M, et al. Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma. J Exp Clin Cancer Res 2011; 30: 108.
44.
Borgogna C, Lanfredini S, Peretti A, et al. Improved detection reveals active -papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol 2014; 27: 1101-1115.
45.
Paradisi A, Waterboer T, Sampogna F, et al. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol 2011; 165: 782-791.
46.
Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88: 802-811.
47.
Wieland U, Stoltidis M, Weissenborn S, et al. Papillomavirus DNA in Basal Cell Carcinomas of Immunocompetent Patients: an Accidental Association? J Invest Dermatol 2000; 115: 124-128.
48.
Andersson K, Michael KM, Luostarinen T, et al. Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol 2012; 175: 685-695.
49.
Faust H, Andersson K, Forslund O, et al. Pseudovirion-binding and neutralizing antibodies to cutaneous Human Papillomaviruses correlated to presence of HPV DNA in skin. J Gen Virol 2013; 94: 1096-1103.
50.
Andersson K, Waterboer T, Kirnbauer R, et al. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008; 17: 189-195.
51.
Sobjanek M, Bien E, Zablotna M, et al. Soluble interleukin-2 receptor and interleukin-2 serum levels in patients with basal cell carcinoma. Postepy Dermatol Alergol 2016; 33: 263-268.
52.
Sobjanek M, Zabłotna M, Szczerkowska-Dobosz A, et al. -2518 A/G MCP-1 but not -403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma. Postepy Dermatol Alergol 2016; 33: 381-385.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
